Dr. Mariella Filbin is a Pediatric Neuro-Oncologist and Principal Investigator at Dana-Farber Cancer Institute and an Assistant Professor of Pediatrics at Harvard Medical School. She earned her MD and Ph.D. in Molecular Biology from the Medical University of Graz, Austria. After a pediatric residency at Boston Children’s Hospital, she completed a subspecialty fellowship in pediatric Hematology/Oncology at the Dana-Farber/Boston Children’s Hospital Cancer and Blood Disorder Center. She joined the faculty at DFCI/BCH as a Pediatric Neuro-Oncologist in July 2017 and became Principal Investigator in July 2018. Her research focuses on high-grade pediatric brain tumors, particularly high-grade gliomas and malignant embryonal brain tumor that are in greatest need of therapeutic improvements. In her studies she is combining single-cell genetics and transcriptomics with gene editing-, epigenetic-, stem cell- and pharmacologic methods to identify networks underlying tumorigenesis, with the goal of establishing new druggable targets.